Trial Profile
Phase II/III trial of a fixed combination of ANAVEX 2-73/donepezil (ANAVEX PLUS) in patients with Alzheimer's disease
Status:
Planning
Phase of Trial:
Phase II/III
Latest Information Update: 22 Jan 2014
Price :
$35
*
At a glance
- Drugs ANAVEX-2-73/donepezil (Primary) ; Donepezil
- Indications Alzheimer's disease
- Focus Adverse reactions; Registrational
- Sponsors Anavex Life Sciences
- 22 Jan 2014 New trial record